The Pharma CI USA Conference & Exhibition just closed the book on another successful event in Newark, New Jersey, maintaining a more than 10-year tradition of being the best and largest assembly of competitive intelligence executives in pharma, biotech, and medical devices. The well-attended event included the deep participation of senior-level speakers from all of the industry’s most respected companies.
The executive keynotes included talks from some of the industry’s most forward-thinking speakers, including Sachin Nanavati, Senior Business Leader for Healthcare at Google (Keynote: “Connected Health at the Speed of Life”) and Roger Longman, Co-founder and Chairman, Real Endpoints LLC (“The Pricing/Access Box”). Another highlight of the event was the Strategic CI Boardroom Executive Level Discussions, featuring competitive intelligence leads from Bayer, BioMarin, Eli Lilly and Company, Johnson & Johnson, Merck & Co., and Novartis.
The vast amount of networking opportunities allowed attendees to reconnect with colleagues and create new contacts. Attendees were able to collaborate, share best practices, and discuss thoughtful and deliberate strategies for success. Pharma CI provides the framework for these meaningful exchanges and will continue to do so in the years to come.
The Pharma CI Conference & Exhibition remains the best and largest assembly of competitive intelligence and market research executives in pharma, biotech, and medical devices in the world for 10+ years. Pharma CI USA plans to continue its success next year, returning to New Jersey on September 30, 2020. For additional information, visit www.pharmaciconference.com.
